Anti⁃CD38 monoclonal antibody daratumumab treatment in severe anti⁃N ⁃methyl⁃D ⁃aspartate receptor encephalitis: one case report
Main Authors: | ZHANG Chao, SHEN Yi, ZHAO Bin, FAN Mo⁃li, XIE Bing⁃di |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2023-12-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/2808 |
Similar Items
-
Anti-N-methyl-D-aspartate receptor encephalitis: analysis of three cases
by: Hui SU, et al.
Published: (2015-07-01) -
Update in the research of anti-N-methyl-D-aspartate receptor encephalitis
by: Jia-wei WANG
Published: (2014-08-01) -
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of severe refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports
by: Hongfei Xue, et al.
Published: (2023-01-01) -
Nonparaneoplastic anti-N-methyl-D-aspartate receptor encephalitis with subclinical hyperthyroidism associated with thyroid antibodies
by: Sukeerthi Busi, et al.
Published: (2021-01-01) -
Anti-N-methyl-D-aspartate Receptor Encephalitis after Herpes Simplex Virus Encephalitis
by: John J. Vaidya
Published: (2024-12-01)